Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Other Working Capital Changes (2016 - 2025)

Avanos Medical's Other Working Capital Changes history spans 11 years, with the latest figure at -$17.7 million for Q4 2024.

  • For Q4 2024, Other Working Capital Changes rose 20.27% year-over-year to -$17.7 million; the TTM value through Dec 2024 reached -$14.9 million, up 33.48%, while the annual FY2025 figure was -$1.4 million, 90.6% up from the prior year.
  • Other Working Capital Changes for Q4 2024 was -$17.7 million at Avanos Medical, down from $600000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $51.5 million in Q3 2021 and bottomed at -$52.1 million in Q2 2021.
  • The 5-year median for Other Working Capital Changes is -$150000.0 (2022), against an average of -$1.8 million.
  • The largest annual shift saw Other Working Capital Changes skyrocketed 5622.22% in 2021 before it plummeted 22100.0% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$1.0 million in 2020, then surged by 400.0% to $3.0 million in 2021, then plummeted by 103.33% to -$100000.0 in 2022, then tumbled by 22100.0% to -$22.2 million in 2023, then grew by 20.27% to -$17.7 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Other Working Capital Changes are -$17.7 million (Q4 2024), $600000.0 (Q3 2024), and $2.0 million (Q2 2024).